In the current study, we aimed to examine whether LAIR-1 influences HCC susceptibility by performing a case-controlled study in a population of Egyptian patients, evaluating the association between HCV G4 post-treatment and liver cirrhosis risk or cirrhosis progression to HCC. The gene discussed is LAIR1; the disease is hepatocellular carcinoma.